Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
3 pending office actions • 2 art units • 2 examiners • 0 of 3 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Altek Biotechnology Corporation currently manages 3 pending office actions within the Medical Devices & Mechanical Engineering technology area. These actions are distributed across 2 distinct examiners and 2 distinct art units. The presence of these units suggests that the company's technical applications are being reviewed in multiple specialized sections of the patent office, which may require distinct arguments tailored to each unit's specific standards and examination practices.
The busiest examiner for this portfolio is GOLOVAN, MARK, who is responsible for a portion of the matters. This concentration means GOLOVAN, MARK handles a significant share of the company's 3 active matters, providing a central point of contact for the current prosecution efforts. Practitioners should note that the busiest examiner oversees the pending workload, which allows for a more unified negotiation strategy across the applications. Having this examiner involved in multiple cases ensures that the company can address similar technical rejections or objections in a consistent manner across the portfolio.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (33%) |
| Multi-statute (no §101) | 2 (67%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GOLOVAN, MARK | 2 | 100.0% | +0.0% |
| NGUYEN, ANDREW H | 1 | 75.1% | +42.5% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18125129 | DRIVING MECHANISM FOR DRIVING A PLUNGER OF AN AUTO-INJECTOR TO SLIDE RELATIVE TO A RESERVOIR OF THE AUTO-INJECTOR AND AUTO-INJECTOR THEREWITH | GOLOVAN, MARK | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18399720 | DRUG DELIVERY DEVICE | NGUYEN, ANDREW H | 9d |
| 18527373 | INSERTING ASSEMBLY AND RELATED AUTOMATED INJECTION SYSTEM | GOLOVAN, MARK | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18399720 | DRUG DELIVERY DEVICE | NGUYEN, ANDREW H | 9d |
| Art Unit | Apps |
|---|---|
| 3783 | 2 |
| 3741 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18399720 | DRUG DELIVERY DEVICE | NGUYEN, ANDREW H | 3741 | §103§112 | Non-Final OA | 9d | Pending | Dec 29, 2023 |
| 18527373 | INSERTING ASSEMBLY AND RELATED AUTOMATED INJECTION SYSTEM | GOLOVAN, MARK | 3783 | §102§112 | Non-Final OA | — | Pending | Dec 04, 2023 |
| 18125129 | DRIVING MECHANISM FOR DRIVING A PLUNGER OF AN AUTO-INJECTOR TO SLIDE RELATIVE TO A RESERVOIR OF THE AUTO-INJECTOR AND AUTO-INJECTOR THEREWITH | GOLOVAN, MARK | 3783 | §112Other | Non-Final OA | — | Pending | Mar 23, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial